Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of Ozempic. This new drug stimulates calorie burning and reduces appetite without causing nausea,

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and osteoarthritis.

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an endocrinologist at Northwell Lenox Hill Hospital, told The Post.

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs Ozempic and Wegovy. Novo Nordisk, the manufacturer of both, recently shared that CagriSema may lead to 10 percent more weight loss than Wegovy.

Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight management but for many people, there are still questions around side effects, accessibility and results.

Scientific breakthrough to prevent negative side effects of weight loss drugs like Ozempic - Millions across the world could benefit from weight loss drugs such as Ozempic